Open Access Open Access  Restricted Access Subscription Access

Bio-Business in Brief:The Case for Ambitious Action in the Public Sector


Affiliations
1 Department of Biotechnology, Government of India, Block 2, 7th Floor, CGO Complex, Lodi Road, New Delhi 110 003, India
2 Institute of Bioinformatics and Applied Biotechnology, Biotech Park, Electronics City Phase I, Bengaluru 560 100, India
 

At the time of independence, India was a poor country. Nevertheless, the Government saw fit to invest in industry and research. In recent decades the public sector has received a bad press, with pressure to reduce it while increasing the role of the private sector. The public sector is not intrinsically bad, but has often been misused. The ‘market’ and the ‘state’ each have a role in economic development. To ensure steady growth of the economy, the country must ensure universal healthcare, for which it needs an innovative homegrown industry and universal good education. This requires large public investment.

Keywords

Basic Research, Biotech Industry, Liberalization, Pharma Industry, Public Sector.
User
Notifications
Font Size


  • Bio-Business in Brief:The Case for Ambitious Action in the Public Sector

Abstract Views: 508  |  PDF Views: 174

Authors

K. Vijay Raghavan
Department of Biotechnology, Government of India, Block 2, 7th Floor, CGO Complex, Lodi Road, New Delhi 110 003, India
Gayatri Saberwal
Institute of Bioinformatics and Applied Biotechnology, Biotech Park, Electronics City Phase I, Bengaluru 560 100, India

Abstract


At the time of independence, India was a poor country. Nevertheless, the Government saw fit to invest in industry and research. In recent decades the public sector has received a bad press, with pressure to reduce it while increasing the role of the private sector. The public sector is not intrinsically bad, but has often been misused. The ‘market’ and the ‘state’ each have a role in economic development. To ensure steady growth of the economy, the country must ensure universal healthcare, for which it needs an innovative homegrown industry and universal good education. This requires large public investment.

Keywords


Basic Research, Biotech Industry, Liberalization, Pharma Industry, Public Sector.

References





DOI: https://doi.org/10.18520/cs%2Fv113%2Fi10%2F1841-1845